Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series Article Swipe
Raul E. Ruiz‐Lozano
,
Hazem M. Mousa
,
Matias Soifer
,
Nadim S. Azar
,
Manuel E. Quiroga-Garza
,
Daliya Dzhaber
,
Sofia Murillo
,
Ailin Song
,
C. Egla Rabinovich
,
Victor L. Perez
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s10792-024-03289-1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s10792-024-03289-1
Purpose Evaluate the response to adalimumab (ADA) in pediatric chronic anterior uveitis (pCAU). Methods Retrospective chart review of pCAU patients treated with ADA. Outcomes evaluated included the proportion of patients achieving zero ocular inflammation and discontinuation of topical corticosteroids, visual outcomes, and incidence of uveitis recurrences after ≥ 12 months of prescribing ADA. Incidence and risk factors for developing anti-adalimumab antibodies (AAAs) were also evaluated. Results Of 27 children aged 11 years, 16 (59%) were Caucasian and 6 (22%) African Americans. Thirteen (48%) patients had idiopathic pCAU, 12 (44%) had juvenile idiopathic arthritis (JIA) related pCAU, and 2 (7%) had tubulointerstitial nephritis and uveitis syndrome. At baseline, African American children had worse visual acuity ( p = 0.026). At 1 year, 21 (78%) children achieved zero ocular inflammation (remission). Risk factors associated with non-remission were being African American (20% vs. 94%, p = 0.003) and experiencing ≥ 1 episode of uveitis recurrence (100% vs. 0%, p < 0.001). Six episodes of uveitis recurrence were documented in five children, four of whom were African American. Topical corticosteroids were discontinued in 83% of children, and visual acuity remained stable for 1 year. Twelve children were tested for AAAs due to arthritis or uveitis flare-ups, with five (42%) being positive. No significant factors were associated with the development of AAAs. Conclusions We found that ADA is effective in controlling inflammation, reducing the need for topical corticosteroids, and maintaining visual acuity in pCAU. There appears to be racial differences in African American children who had worse baseline disease and poorer outcomes. Studies are necessary to understand better and address these disparities.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s10792-024-03289-1
- OA Status
- hybrid
- Cited By
- 1
- References
- 31
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4402407399
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4402407399Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s10792-024-03289-1Digital Object Identifier
- Title
-
Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case seriesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-09-10Full publication date if available
- Authors
-
Raul E. Ruiz‐Lozano, Hazem M. Mousa, Matias Soifer, Nadim S. Azar, Manuel E. Quiroga-Garza, Daliya Dzhaber, Sofia Murillo, Ailin Song, C. Egla Rabinovich, Victor L. PerezList of authors in order
- Landing page
-
https://doi.org/10.1007/s10792-024-03289-1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1007/s10792-024-03289-1Direct OA link when available
- Concepts
-
Medicine, Adalimumab, Uveitis, Incidence (geometry), Discontinuation, Visual acuity, Oligoarthritis, Arthritis, Pediatrics, Dermatology, Internal medicine, Surgery, Ophthalmology, Disease, Polyarthritis, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
31Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4402407399 |
|---|---|
| doi | https://doi.org/10.1007/s10792-024-03289-1 |
| ids.doi | https://doi.org/10.1007/s10792-024-03289-1 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39254907 |
| ids.openalex | https://openalex.org/W4402407399 |
| fwci | 1.19478638 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D002648 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Child |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000068879 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Adalimumab |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D008297 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Male |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D012189 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Retrospective Studies |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D014606 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Uveitis, Anterior |
| mesh[7].qualifier_ui | Q000175 |
| mesh[7].descriptor_ui | D014606 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | diagnosis |
| mesh[7].descriptor_name | Uveitis, Anterior |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D014792 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Visual Acuity |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D002908 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Chronic Disease |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D000893 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Anti-Inflammatory Agents |
| mesh[11].qualifier_ui | Q000008 |
| mesh[11].descriptor_ui | D000893 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | administration & dosage |
| mesh[11].descriptor_name | Anti-Inflammatory Agents |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000293 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Adolescent |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D016896 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Treatment Outcome |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D005500 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Follow-Up Studies |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D002675 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Child, Preschool |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D002648 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Child |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D000068879 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Adalimumab |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D008297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Male |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D012189 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Retrospective Studies |
| mesh[22].qualifier_ui | Q000188 |
| mesh[22].descriptor_ui | D014606 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | drug therapy |
| mesh[22].descriptor_name | Uveitis, Anterior |
| mesh[23].qualifier_ui | Q000175 |
| mesh[23].descriptor_ui | D014606 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | diagnosis |
| mesh[23].descriptor_name | Uveitis, Anterior |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D014792 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Visual Acuity |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D002908 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Chronic Disease |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D000893 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Anti-Inflammatory Agents |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D000893 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Anti-Inflammatory Agents |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000293 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Adolescent |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D016896 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Treatment Outcome |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D005500 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Follow-Up Studies |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D002675 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Child, Preschool |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D006801 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Humans |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D002648 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Child |
| mesh[34].qualifier_ui | Q000627 |
| mesh[34].descriptor_ui | D000068879 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | therapeutic use |
| mesh[34].descriptor_name | Adalimumab |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008297 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Male |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D005260 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Female |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D012189 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Retrospective Studies |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D014606 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | Uveitis, Anterior |
| mesh[39].qualifier_ui | Q000175 |
| mesh[39].descriptor_ui | D014606 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | diagnosis |
| mesh[39].descriptor_name | Uveitis, Anterior |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D014792 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Visual Acuity |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D002908 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Chronic Disease |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D000893 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Anti-Inflammatory Agents |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D000893 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | Anti-Inflammatory Agents |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D000293 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Adolescent |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D016896 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Treatment Outcome |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D005500 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Follow-Up Studies |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D002675 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Child, Preschool |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D002648 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Child |
| type | article |
| title | Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series |
| biblio.issue | 1 |
| biblio.volume | 44 |
| biblio.last_page | 376 |
| biblio.first_page | 376 |
| topics[0].id | https://openalex.org/T11194 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Ocular Diseases and Behçet’s Syndrome |
| topics[1].id | https://openalex.org/T10308 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976999759674072 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Systemic Lupus Erythematosus Research |
| topics[2].id | https://openalex.org/T11616 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9965999722480774 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2720 |
| topics[2].subfield.display_name | Hematology |
| topics[2].display_name | Autoimmune and Inflammatory Disorders Research |
| is_xpac | False |
| apc_list.value | 2690 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3390 |
| apc_paid.value | 2690 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 3390 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9757993221282959 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780132546 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8574062585830688 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q348260 |
| concepts[1].display_name | Adalimumab |
| concepts[2].id | https://openalex.org/C2776194053 |
| concepts[2].level | 2 |
| concepts[2].score | 0.8460657000541687 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q280027 |
| concepts[2].display_name | Uveitis |
| concepts[3].id | https://openalex.org/C61511704 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6409172415733337 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[3].display_name | Incidence (geometry) |
| concepts[4].id | https://openalex.org/C2778715236 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6362716555595398 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q55622662 |
| concepts[4].display_name | Discontinuation |
| concepts[5].id | https://openalex.org/C2778257484 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5509655475616455 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q555066 |
| concepts[5].display_name | Visual acuity |
| concepts[6].id | https://openalex.org/C2780366729 |
| concepts[6].level | 4 |
| concepts[6].score | 0.442855566740036 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3350500 |
| concepts[6].display_name | Oligoarthritis |
| concepts[7].id | https://openalex.org/C2777077863 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4391981065273285 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q170990 |
| concepts[7].display_name | Arthritis |
| concepts[8].id | https://openalex.org/C187212893 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3783065676689148 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[8].display_name | Pediatrics |
| concepts[9].id | https://openalex.org/C16005928 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3202345371246338 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[9].display_name | Dermatology |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3010422885417938 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C141071460 |
| concepts[11].level | 1 |
| concepts[11].score | 0.29307106137275696 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[11].display_name | Surgery |
| concepts[12].id | https://openalex.org/C118487528 |
| concepts[12].level | 1 |
| concepts[12].score | 0.2664916515350342 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[12].display_name | Ophthalmology |
| concepts[13].id | https://openalex.org/C2779134260 |
| concepts[13].level | 2 |
| concepts[13].score | 0.24536922574043274 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[13].display_name | Disease |
| concepts[14].id | https://openalex.org/C2778917330 |
| concepts[14].level | 3 |
| concepts[14].score | 0.19459667801856995 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1274464 |
| concepts[14].display_name | Polyarthritis |
| concepts[15].id | https://openalex.org/C121332964 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[15].display_name | Physics |
| concepts[16].id | https://openalex.org/C120665830 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[16].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9757993221282959 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/adalimumab |
| keywords[1].score | 0.8574062585830688 |
| keywords[1].display_name | Adalimumab |
| keywords[2].id | https://openalex.org/keywords/uveitis |
| keywords[2].score | 0.8460657000541687 |
| keywords[2].display_name | Uveitis |
| keywords[3].id | https://openalex.org/keywords/incidence |
| keywords[3].score | 0.6409172415733337 |
| keywords[3].display_name | Incidence (geometry) |
| keywords[4].id | https://openalex.org/keywords/discontinuation |
| keywords[4].score | 0.6362716555595398 |
| keywords[4].display_name | Discontinuation |
| keywords[5].id | https://openalex.org/keywords/visual-acuity |
| keywords[5].score | 0.5509655475616455 |
| keywords[5].display_name | Visual acuity |
| keywords[6].id | https://openalex.org/keywords/oligoarthritis |
| keywords[6].score | 0.442855566740036 |
| keywords[6].display_name | Oligoarthritis |
| keywords[7].id | https://openalex.org/keywords/arthritis |
| keywords[7].score | 0.4391981065273285 |
| keywords[7].display_name | Arthritis |
| keywords[8].id | https://openalex.org/keywords/pediatrics |
| keywords[8].score | 0.3783065676689148 |
| keywords[8].display_name | Pediatrics |
| keywords[9].id | https://openalex.org/keywords/dermatology |
| keywords[9].score | 0.3202345371246338 |
| keywords[9].display_name | Dermatology |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.3010422885417938 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/surgery |
| keywords[11].score | 0.29307106137275696 |
| keywords[11].display_name | Surgery |
| keywords[12].id | https://openalex.org/keywords/ophthalmology |
| keywords[12].score | 0.2664916515350342 |
| keywords[12].display_name | Ophthalmology |
| keywords[13].id | https://openalex.org/keywords/disease |
| keywords[13].score | 0.24536922574043274 |
| keywords[13].display_name | Disease |
| keywords[14].id | https://openalex.org/keywords/polyarthritis |
| keywords[14].score | 0.19459667801856995 |
| keywords[14].display_name | Polyarthritis |
| language | en |
| locations[0].id | doi:10.1007/s10792-024-03289-1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S47727624 |
| locations[0].source.issn | 0165-5701, 1573-2630 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0165-5701 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | International Ophthalmology |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Ophthalmology |
| locations[0].landing_page_url | https://doi.org/10.1007/s10792-024-03289-1 |
| locations[1].id | pmid:39254907 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | International ophthalmology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39254907 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11387437 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Int Ophthalmol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11387437 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5059072672 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7022-2395 |
| authorships[0].author.display_name | Raul E. Ruiz‐Lozano |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I145608581 |
| authorships[0].affiliations[1].raw_affiliation_string | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. |
| authorships[0].institutions[0].id | https://openalex.org/I170897317 |
| authorships[0].institutions[0].ror | https://ror.org/00py81415 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Duke University |
| authorships[0].institutions[1].id | https://openalex.org/I145608581 |
| authorships[0].institutions[1].ror | https://ror.org/02dgjyy92 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I145608581 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | University of Miami |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Raul E Ruiz-Lozano |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA., Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[1].author.id | https://openalex.org/A5021993493 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4213-7358 |
| authorships[1].author.display_name | Hazem M. Mousa |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I170897317 |
| authorships[1].institutions[0].ror | https://ror.org/00py81415 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Duke University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hazem M Mousa |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[2].author.id | https://openalex.org/A5070858325 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8695-2541 |
| authorships[2].author.display_name | Matias Soifer |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I145608581 |
| authorships[2].affiliations[0].raw_affiliation_string | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I170897317 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I170897317 |
| authorships[2].institutions[0].ror | https://ror.org/00py81415 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Duke University |
| authorships[2].institutions[1].id | https://openalex.org/I145608581 |
| authorships[2].institutions[1].ror | https://ror.org/02dgjyy92 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I145608581 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | University of Miami |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Matias Soifer |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA., Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[3].author.id | https://openalex.org/A5051806464 |
| authorships[3].author.orcid | https://orcid.org/0009-0004-3544-7184 |
| authorships[3].author.display_name | Nadim S. Azar |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I170897317 |
| authorships[3].institutions[0].ror | https://ror.org/00py81415 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Duke University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nadim S Azar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[4].author.id | https://openalex.org/A5081318900 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5237-240X |
| authorships[4].author.display_name | Manuel E. Quiroga-Garza |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145608581 |
| authorships[4].affiliations[0].raw_affiliation_string | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I170897317 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[4].institutions[0].id | https://openalex.org/I170897317 |
| authorships[4].institutions[0].ror | https://ror.org/00py81415 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Duke University |
| authorships[4].institutions[1].id | https://openalex.org/I145608581 |
| authorships[4].institutions[1].ror | https://ror.org/02dgjyy92 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I145608581 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of Miami |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Manuel E Quiroga-Garza |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA., Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[5].author.id | https://openalex.org/A5069336048 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6468-884X |
| authorships[5].author.display_name | Daliya Dzhaber |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[5].institutions[0].id | https://openalex.org/I170897317 |
| authorships[5].institutions[0].ror | https://ror.org/00py81415 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Duke University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Daliya Dzhaber |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[6].author.id | https://openalex.org/A5075072974 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8406-2318 |
| authorships[6].author.display_name | Sofia Murillo |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I180670191 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Pediatrics, University of California, San Francisco, San Francisco, CA, 94143, USA. |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I170897317 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[6].institutions[0].id | https://openalex.org/I170897317 |
| authorships[6].institutions[0].ror | https://ror.org/00py81415 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Duke University |
| authorships[6].institutions[1].id | https://openalex.org/I180670191 |
| authorships[6].institutions[1].ror | https://ror.org/043mz5j54 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I180670191 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | University of California, San Francisco |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sofia Murillo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA., Department of Pediatrics, University of California, San Francisco, San Francisco, CA, 94143, USA. |
| authorships[7].author.id | https://openalex.org/A5024538728 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8451-054X |
| authorships[7].author.display_name | Ailin Song |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[7].institutions[0].id | https://openalex.org/I170897317 |
| authorships[7].institutions[0].ror | https://ror.org/00py81415 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Duke University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ailin Song |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[8].author.id | https://openalex.org/A5063508611 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | C. Egla Rabinovich |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210144876 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Pediatrics, Duke University Health System, Durham, NC, 27705, USA. |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I170897317 |
| authorships[8].affiliations[1].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. |
| authorships[8].institutions[0].id | https://openalex.org/I170897317 |
| authorships[8].institutions[0].ror | https://ror.org/00py81415 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Duke University |
| authorships[8].institutions[1].id | https://openalex.org/I4210144876 |
| authorships[8].institutions[1].ror | https://ror.org/03wfqwh68 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210144876 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | Duke University Health System |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | C Egla Rabinovich |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA., Department of Pediatrics, Duke University Health System, Durham, NC, 27705, USA. |
| authorships[9].author.id | https://openalex.org/A5100642346 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2983-0847 |
| authorships[9].author.display_name | Victor L. Perez |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. [email protected]. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I145608581 |
| authorships[9].affiliations[1].raw_affiliation_string | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. [email protected]. |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I145608581 |
| authorships[9].affiliations[2].raw_affiliation_string | McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th St, Miami, FL, 33136, USA. [email protected]. |
| authorships[9].institutions[0].id | https://openalex.org/I170897317 |
| authorships[9].institutions[0].ror | https://ror.org/00py81415 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Duke University |
| authorships[9].institutions[1].id | https://openalex.org/I145608581 |
| authorships[9].institutions[1].ror | https://ror.org/02dgjyy92 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I145608581 |
| authorships[9].institutions[1].country_code | US |
| authorships[9].institutions[1].display_name | University of Miami |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Victor L Perez |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. [email protected]., Department of Ophthalmology, Foster Center for Ocular Immunology at Duke Eye Center, Duke University School of Medicine, Durham, NC, USA. [email protected]., McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th St, Miami, FL, 33136, USA. [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1007/s10792-024-03289-1 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11194 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Ocular Diseases and Behçet’s Syndrome |
| related_works | https://openalex.org/W4295419430, https://openalex.org/W2914954351, https://openalex.org/W204144727, https://openalex.org/W4378516095, https://openalex.org/W2011992714, https://openalex.org/W4295440226, https://openalex.org/W2107736213, https://openalex.org/W2609140842, https://openalex.org/W1980435761, https://openalex.org/W4310588830 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s10792-024-03289-1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S47727624 |
| best_oa_location.source.issn | 0165-5701, 1573-2630 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0165-5701 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | International Ophthalmology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Ophthalmology |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s10792-024-03289-1 |
| primary_location.id | doi:10.1007/s10792-024-03289-1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S47727624 |
| primary_location.source.issn | 0165-5701, 1573-2630 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0165-5701 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | International Ophthalmology |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Ophthalmology |
| primary_location.landing_page_url | https://doi.org/10.1007/s10792-024-03289-1 |
| publication_date | 2024-09-10 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2115616020, https://openalex.org/W2469914834, https://openalex.org/W2941455980, https://openalex.org/W2011782096, https://openalex.org/W2064325706, https://openalex.org/W3178912115, https://openalex.org/W2160921275, https://openalex.org/W1176283365, https://openalex.org/W2141395406, https://openalex.org/W2524978046, https://openalex.org/W2517470674, https://openalex.org/W2510021462, https://openalex.org/W2985758722, https://openalex.org/W2883946064, https://openalex.org/W2059066086, https://openalex.org/W2139499737, https://openalex.org/W2096903378, https://openalex.org/W2608059792, https://openalex.org/W2914954351, https://openalex.org/W2164118913, https://openalex.org/W2905992196, https://openalex.org/W2168908756, https://openalex.org/W2026701492, https://openalex.org/W1487297305, https://openalex.org/W1967335955, https://openalex.org/W4231847001, https://openalex.org/W2140539537, https://openalex.org/W1997158276, https://openalex.org/W1683001056, https://openalex.org/W1530431523, https://openalex.org/W2077177293 |
| referenced_works_count | 31 |
| abstract_inverted_index.( | 115 |
| abstract_inverted_index.1 | 120, 148, 189 |
| abstract_inverted_index.2 | 98 |
| abstract_inverted_index.6 | 78 |
| abstract_inverted_index.= | 117, 143 |
| abstract_inverted_index.p | 116, 142, 156 |
| abstract_inverted_index.11 | 71 |
| abstract_inverted_index.12 | 49, 88 |
| abstract_inverted_index.16 | 73 |
| abstract_inverted_index.21 | 122 |
| abstract_inverted_index.27 | 68 |
| abstract_inverted_index.At | 106, 119 |
| abstract_inverted_index.No | 208 |
| abstract_inverted_index.Of | 67 |
| abstract_inverted_index.We | 219 |
| abstract_inverted_index.be | 243 |
| abstract_inverted_index.in | 8, 166, 179, 225, 238, 246 |
| abstract_inverted_index.is | 223 |
| abstract_inverted_index.of | 18, 29, 37, 44, 51, 150, 161, 170, 181, 216 |
| abstract_inverted_index.or | 200 |
| abstract_inverted_index.to | 5, 198, 242, 261 |
| abstract_inverted_index.0%, | 155 |
| abstract_inverted_index.83% | 180 |
| abstract_inverted_index.ADA | 222 |
| abstract_inverted_index.Six | 159 |
| abstract_inverted_index.and | 35, 42, 55, 77, 97, 103, 145, 183, 234, 255, 264 |
| abstract_inverted_index.are | 259 |
| abstract_inverted_index.due | 197 |
| abstract_inverted_index.for | 58, 188, 195, 231 |
| abstract_inverted_index.had | 85, 90, 100, 111, 251 |
| abstract_inverted_index.the | 3, 27, 214, 229 |
| abstract_inverted_index.vs. | 140, 154 |
| abstract_inverted_index.who | 250 |
| abstract_inverted_index.≥ | 48, 147 |
| abstract_inverted_index.< | 157 |
| abstract_inverted_index.(20% | 139 |
| abstract_inverted_index.(7%) | 99 |
| abstract_inverted_index.94%, | 141 |
| abstract_inverted_index.AAAs | 196 |
| abstract_inverted_index.ADA. | 23, 53 |
| abstract_inverted_index.Risk | 130 |
| abstract_inverted_index.aged | 70 |
| abstract_inverted_index.also | 64 |
| abstract_inverted_index.five | 167, 204 |
| abstract_inverted_index.four | 169 |
| abstract_inverted_index.need | 230 |
| abstract_inverted_index.pCAU | 19 |
| abstract_inverted_index.risk | 56 |
| abstract_inverted_index.that | 221 |
| abstract_inverted_index.were | 63, 75, 135, 164, 172, 177, 193, 211 |
| abstract_inverted_index.whom | 171 |
| abstract_inverted_index.with | 22, 133, 203, 213 |
| abstract_inverted_index.zero | 32, 126 |
| abstract_inverted_index.(100% | 153 |
| abstract_inverted_index.(22%) | 79 |
| abstract_inverted_index.(42%) | 205 |
| abstract_inverted_index.(44%) | 89 |
| abstract_inverted_index.(48%) | 83 |
| abstract_inverted_index.(59%) | 74 |
| abstract_inverted_index.(78%) | 123 |
| abstract_inverted_index.(ADA) | 7 |
| abstract_inverted_index.(JIA) | 94 |
| abstract_inverted_index.AAAs. | 217 |
| abstract_inverted_index.There | 240 |
| abstract_inverted_index.after | 47 |
| abstract_inverted_index.being | 136, 206 |
| abstract_inverted_index.chart | 16 |
| abstract_inverted_index.found | 220 |
| abstract_inverted_index.pCAU, | 87, 96 |
| abstract_inverted_index.pCAU. | 239 |
| abstract_inverted_index.these | 266 |
| abstract_inverted_index.worse | 112, 252 |
| abstract_inverted_index.year, | 121 |
| abstract_inverted_index.year. | 190 |
| abstract_inverted_index.(AAAs) | 62 |
| abstract_inverted_index.0.003) | 144 |
| abstract_inverted_index.Twelve | 191 |
| abstract_inverted_index.acuity | 114, 185, 237 |
| abstract_inverted_index.better | 263 |
| abstract_inverted_index.months | 50 |
| abstract_inverted_index.ocular | 33, 127 |
| abstract_inverted_index.poorer | 256 |
| abstract_inverted_index.racial | 244 |
| abstract_inverted_index.review | 17 |
| abstract_inverted_index.stable | 187 |
| abstract_inverted_index.tested | 194 |
| abstract_inverted_index.visual | 40, 113, 184, 236 |
| abstract_inverted_index.years, | 72 |
| abstract_inverted_index.(pCAU). | 13 |
| abstract_inverted_index.0.001). | 158 |
| abstract_inverted_index.0.026). | 118 |
| abstract_inverted_index.African | 80, 108, 137, 173, 247 |
| abstract_inverted_index.Methods | 14 |
| abstract_inverted_index.Purpose | 1 |
| abstract_inverted_index.Results | 66 |
| abstract_inverted_index.Studies | 258 |
| abstract_inverted_index.Topical | 175 |
| abstract_inverted_index.address | 265 |
| abstract_inverted_index.appears | 241 |
| abstract_inverted_index.chronic | 10 |
| abstract_inverted_index.disease | 254 |
| abstract_inverted_index.episode | 149 |
| abstract_inverted_index.factors | 57, 131, 210 |
| abstract_inverted_index.related | 95 |
| abstract_inverted_index.topical | 38, 232 |
| abstract_inverted_index.treated | 21 |
| abstract_inverted_index.uveitis | 12, 45, 104, 151, 162, 201 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.American | 109, 138, 248 |
| abstract_inverted_index.Evaluate | 2 |
| abstract_inverted_index.Outcomes | 24 |
| abstract_inverted_index.Thirteen | 82 |
| abstract_inverted_index.achieved | 125 |
| abstract_inverted_index.anterior | 11 |
| abstract_inverted_index.baseline | 253 |
| abstract_inverted_index.children | 69, 110, 124, 192, 249 |
| abstract_inverted_index.episodes | 160 |
| abstract_inverted_index.included | 26 |
| abstract_inverted_index.juvenile | 91 |
| abstract_inverted_index.patients | 20, 30, 84 |
| abstract_inverted_index.reducing | 228 |
| abstract_inverted_index.remained | 186 |
| abstract_inverted_index.response | 4 |
| abstract_inverted_index.American. | 174 |
| abstract_inverted_index.Caucasian | 76 |
| abstract_inverted_index.Incidence | 54 |
| abstract_inverted_index.achieving | 31 |
| abstract_inverted_index.arthritis | 93, 199 |
| abstract_inverted_index.baseline, | 107 |
| abstract_inverted_index.children, | 168, 182 |
| abstract_inverted_index.effective | 224 |
| abstract_inverted_index.evaluated | 25 |
| abstract_inverted_index.incidence | 43 |
| abstract_inverted_index.necessary | 260 |
| abstract_inverted_index.nephritis | 102 |
| abstract_inverted_index.outcomes, | 41 |
| abstract_inverted_index.outcomes. | 257 |
| abstract_inverted_index.pediatric | 9 |
| abstract_inverted_index.positive. | 207 |
| abstract_inverted_index.syndrome. | 105 |
| abstract_inverted_index.Americans. | 81 |
| abstract_inverted_index.adalimumab | 6 |
| abstract_inverted_index.antibodies | 61 |
| abstract_inverted_index.associated | 132, 212 |
| abstract_inverted_index.developing | 59 |
| abstract_inverted_index.documented | 165 |
| abstract_inverted_index.evaluated. | 65 |
| abstract_inverted_index.flare-ups, | 202 |
| abstract_inverted_index.idiopathic | 86, 92 |
| abstract_inverted_index.proportion | 28 |
| abstract_inverted_index.recurrence | 152, 163 |
| abstract_inverted_index.understand | 262 |
| abstract_inverted_index.Conclusions | 218 |
| abstract_inverted_index.controlling | 226 |
| abstract_inverted_index.development | 215 |
| abstract_inverted_index.differences | 245 |
| abstract_inverted_index.maintaining | 235 |
| abstract_inverted_index.prescribing | 52 |
| abstract_inverted_index.recurrences | 46 |
| abstract_inverted_index.significant | 209 |
| abstract_inverted_index.(remission). | 129 |
| abstract_inverted_index.discontinued | 178 |
| abstract_inverted_index.disparities. | 267 |
| abstract_inverted_index.experiencing | 146 |
| abstract_inverted_index.inflammation | 34, 128 |
| abstract_inverted_index.Retrospective | 15 |
| abstract_inverted_index.inflammation, | 227 |
| abstract_inverted_index.non-remission | 134 |
| abstract_inverted_index.anti-adalimumab | 60 |
| abstract_inverted_index.corticosteroids | 176 |
| abstract_inverted_index.discontinuation | 36 |
| abstract_inverted_index.corticosteroids, | 39, 233 |
| abstract_inverted_index.tubulointerstitial | 101 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.7400000095367432 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.7210646 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |